Blastomycosis
📧 Sign up to get email alerts when something new happens for Blastomycosis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-12EMA Authorised: Posaconazole Accord (posaconazole) — Accord Healthcare S.L.U.
Authorised status for Posaconazole Accord, MAH Accord Healthcare S.L.U., in the therapeutic area of mycoses.
-
FDA approval · 2025-06-02FDA Approved: AMPHOTERICIN B — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original application for Amphotericin B as a generic drug by Heritage Pharmaceuticals (Avet) to treat serious systemic funga…
-
FDA approval · 2025-03-12FDA Approved: ITRACONAZOLE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for itraconazole from Ascend Laboratories, LLC, authorizing changes to the generic product under AND…
-
FDA approval · 2025-01-29FDA Approved: ITRACONAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for itraconazole by Camber Pharmaceuticals, expanding/updating labeling for the generic product.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment [Phase 3]
Phase 3 study assessing ibrexafungerp in patients with invasive and mucocutaneous fungal diseases refractory to or intolerant of standard tr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-10-24FDA Approved: ITRACONAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for itraconazole from Alembic Pharmaceuticals Inc., resulting in a label-related approval update for…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica.
A completed clinical trial conducted at three Costa Rican hospitals evaluating therapies for rare dermatological infections, including sporo…
-
FDA approval · 2023-07-17FDA Approved: FLUCONAZOLE IN SODIUM CHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for Fluconazole in Sodium Chloride, establishing an intravenous formulation of fluconazole. …
-
FDA approval · 2022-11-17FDA Approved: AMPHOTERICIN B — Original Application (Eugia US LLC)
FDA approved the original ANDA for Amphotericin B from Eugia US LLC, authorizing a generic Amphotericin B product.
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: Amphotericin-B and Voriconazole for Pulmonary Blastomycosis [Phase 4]
Phase 4 clinical trial update on amphotericin-B and voriconazole for pulmonary blastomycosis has been terminated.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection
A completed clinical trial from the National Cancer Institute evaluating whether polymorphisms in innate immune genes are associated with th…
-
FDA approval · 2016-09-26FDA Approved: ITRACONAZOLE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for itraconazole, granting a generic version of the antifungal medication. Th…
-
FDA approval · 2015-10-30FDA Approved: ITRACONAZOLE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original ANDA for itraconazole, enabling a generic version of the antifungal agent to be marketed.
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection [Phase 3]
Phase 3 pharmacokinetic study of the itraconazole oral solution JK1211 (Itrizole) in patients with invasive fungal infections; results have …
-
FDA approval · 2011-08-25FDA Approved: KETOCONAZOLE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Padagis Israel Pharmaceuticals Ltd's Ketoconazole original application (ANDA 091550) for a generic ketoconazole product.
-
FDA approval · 2010-03-05FDA Approved: AMPHOTERICIN B — Supplemental Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved a supplemental application for Amphotericin B submitted by XGen Pharmaceuticals DJB, Inc. This approval authorizes a change to …
-
CLINICAL_TRIALS trial_result · 2006-06-09Clinical Trial Update: Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis [Phase 2]
Phase II pilot study evaluating fluconazole for histoplasmosis, sporotrichosis, and blastomycosis has completed.
-
CLINICAL_TRIALS trial_result · 2006-06-09Clinical Trial Update: Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis [Phase 1, Phase 2]
Phase I/II clinical trial update evaluating itraconazole for histoplasmosis, sporotrichosis, and blastomycosis; the study status is complete…